The Fragility Fractures in Focus podcast series by UCB is TARGETED AT HEALTHCARE PROFESSIONALS with the intention of exploring scientific advancements and providing a platform for peer-to-peer discussion on the topic of osteoporosis.

In this episode, “From Bench to Bedside: Integrating Research and Patient Perspectives into Practice”, our host, Cesar Libanati, Senior Consultant in Medical Affairs at UCB, welcomes John Carey, Professor and Consultant Rheumatologist, University of Galway, Ireland. They delve into the growing body of research emphasizing the critical role of secondary fracture prevention, particularly in patients with osteoporosis or other bone health issues. The discussion focuses on the latest evidence supporting proactive interventions and strategies that healthcare professionals can implement to optimize post-fracture care pathways, reducing the risk of subsequent fractures and improving long-term patient outcomes.

This educational podcast has been fully sponsored by UCB and the content does not necessarily reflect the views of UCB. As a pharmaceutical company, UCB adheres to the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code of Practice.

Speaker disclosures:

John Carey has received consulting fees, research or institutional support and/or educational grants from UCB.

Hosted on Acast. See acast.com/privacy for more information.

The Fragility Fractures in Focus podcast series by UCB is TARGETED AT HEALTHCARE PROFESSIONALS with the intention of exploring scientific advancements and providing a platform for peer-to-peer discussion on the topic of osteoporosis.

In this episode, “Closing the gap: It’s make or break for post-fracture care”, host, Cesar Libanati, Senior Consultant in Medical Affairs at UCB, welcomes Professor of Osteoporosis and Adult Rare Bone Diseases, University of Oxford, Kassim Javaid and patient representative, Jennifer Fraser, to discuss the importance of secondary fracture prevention and solutions healthcare professionals can implement to optimize post-fracture care pathways.

This educational podcast has been fully sponsored by UCB and the content does not necessarily reflect the views of UCB. As a pharmaceutical company, UCB adheres to the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code of Practice.

Speaker disclosures:

Kassim Javaid and Jennifer Fraser have received consulting fees, research or institutional support and/ or educational grants from UCB.

For healthcare professionals only.

Date of preparation: February 2024 l GL-DA-2400092

© UCB Biopharma SRL, 2024. All rights reserved.

Hosted on Acast. See acast.com/privacy for more information.

The Fragility Fractures in Focus podcast series by UCB is TARGETED AT HEALTHCARE PROFESSIONALS with the intention of exploring scientific advancements and providing a platform for peer-to-peer discussion on the topic of osteoporosis.

In this episode, “This Time, It’s Personal”, host, Cesar Libanati, Head of Medical External Affairs at UCB, welcomes Professor of Metabolic Bone Disease and Consultant Rheumatologist at NIHR Cambridge Biomedical Research Centre, University of Cambridge, Dr Ken Poole, to discuss how personalization of fracture risk assessment and osteoporosis management, supported by digital technology, has the potential to optimize outcomes for patients.

You can find further information about the podcast series here: UCB rounds off the 2023 podcast series with the two bone health congresses - FFN & ASBMR | UCB

This podcast is only for use by healthcare professionals.

This educational podcast has been fully sponsored by UCB and the content does not necessarily reflect the views of UCB. As a pharmaceutical company, UCB adheres to the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code of Practice.

Speaker Disclosures:

Dr Ken Poole has received consulting fees, research or institutional support and/ or educational grants from UCB.

For healthcare professionals only.

Date of preparation: September 2023 l GL-DA-2300156

© UCB Biopharma SRL, 2023. All rights reserved.

Hosted on Acast. See acast.com/privacy for more information.